BioNxt Solutions Inc. (OTCMKTS:BNXTF) Short Interest Update

BioNxt Solutions Inc. (OTCMKTS:BNXTF) saw a large decline in short interest in the month of June. As of June 15th, there was short interest totalling 1,000 shares, a decline of 56.5% from the May 31st total of 2,300 shares. Based on an average trading volume of 1,200 shares, the short-interest ratio is presently 0.8 days.

BioNxt Solutions Price Performance

Shares of BioNxt Solutions stock remained flat at $0.23 during trading on Friday. 360 shares of the company were exchanged, compared to its average volume of 1,365. BioNxt Solutions has a 52 week low of $0.00 and a 52 week high of $0.57. The company has a fifty day moving average price of $0.26 and a 200 day moving average price of $0.37.

BioNxt Solutions (OTCMKTS:BNXTF) last released its earnings results on Wednesday, May 29th. The company reported ($0.01) earnings per share (EPS) for the quarter.

BioNxt Solutions Company Profile

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.